Arianna Zangrilli

12PUBLICATIONS
34CO-AUTHORS
Infant and child healthClinical pharmacology and therapeuticsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Traditional Chinese medicine and treatmentsAllergy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Jul 04, 2025
Effectiveness and Safety of Adalimumab Biosimilars in Pediatric Psoriasis: A Multi-Center International Experience.

Cristina Bertoli, Tiago Torres, Paolo Romita

|Apr 06, 2022
Risankizumab for the treatment of moderate-to-severe psoriasis: A multicenter, retrospective, 1 year real-life study.

Giacomo Caldarola, Arianna Zangrilli, Nicoletta Bernardini

|Jul 19, 2021
Predictive factors of lack of response to adalimumab among bio-naive patients suffering from moderate-to severe psoriasis: analysis of a multicenter data collection in Italy.

Arianna Zangrilli, Giacomo Caldarola, Nicoletta Bernardini

|Nov 11, 2020
A linear forehead lesion caused by intralesional injection of triamcinolone acetonide and treated with hyaluronic acid filler: Case report.

Arianna Piccolo, Chiara Pensa, Arianna Zangrilli

|Oct 29, 2020
Paradoxical Psoriasis Induced by Anti-TNFα Treatment: Evaluation of Disease-Specific Clinical and Genetic Markers.

Agostino Bucalo, Federica Rega, Arianna Zangrilli

|Oct 06, 2020
Risankizumab: How to choose the right dose in clinical practice?

Chiara Pensa, Arianna Piccolo, Arianna Zangrilli

Pageof 2

Frequent Collaborators

7 joint publications

Mauro Bavetta

4 joint publications

Luca Bianchi

3 joint publications

Arianna Piccolo

3 joint publications

Chiara Pensa